SMTL ID : 6y7f.1

Crystal structure of human ELOVL fatty acid elongase 7 (ELOVL7)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

homo-dimer

Ligands

2 x OFN: ~{S}-[2-[3-[[(2~{R})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] 3-oxidanylideneicosanethioate(Covalent)

OFN.1: 45 residues within 4Å: Chain A: M.68, Y.71, N.72, K.124, D.130, F.133, F.134, R.137, K.139, Q.142, L.146, H.147, H.150, H.151, M.154, T.157, W.158, G.161, A.165, G.170, H.173, N.177, H.181, M.184, Y.185, Y.187, Y.188, S.191, A.192, Q.198, K.204, L.207, T.208, Q.211, F.215, F.238, I.241, I.242, Y.245, S.246, F.249, F.253, F.256, R.266, K.269 29 PLIP interactions: 29 interactions with chain A Hydrophobic interactions: A:L.146, A:T.157, A:Y.187, A:K.204, A:F.215, A:I.241, A:Y.245, A:Y.245, A:F.249 Hydrogen bonds: A:N.72, A:N.72, A:Q.142, A:N.177, A:Q.198, A:Q.211 Water bridges: A:E.127, A:D.130, A:R.137, A:K.139, A:Y.188, A:Y.188, A:R.266 Salt bridges: A:R.137, A:K.139, A:K.204, A:K.204, A:R.266, A:R.266, A:K.269 OFN.6: 41 residues within 4Å: Chain B: M.68, Y.71, N.72, K.124, D.130, F.133, F.134, R.137, K.139, Q.142, L.146, H.147, H.150, M.154, T.157, W.158, G.161, A.165, G.170, H.173, N.177, H.181, M.184, Y.185, Y.187, Y.188, S.191, A.192, Q.198, K.204, L.207, T.208, Q.211, F.215, F.238, I.241, I.242, Y.245, F.253, F.256, R.266 26 PLIP interactions: 26 interactions with chain B Hydrophobic interactions: B:L.146, B:Y.187, B:K.204, B:F.215, B:F.238, B:I.241, B:Y.245, B:Y.245 Hydrogen bonds: B:N.72, B:N.72, B:D.130, B:Q.142, B:N.177, B:Y.187, B:Y.188, B:Q.198, B:Q.211 Water bridges: B:R.137, B:K.139, B:R.266 Salt bridges: B:R.137, B:K.139, B:K.204, B:K.204, B:R.266, B:R.266

4 x 37X: Octyl Glucose Neopentyl Glycol(Non-covalent)

37X.2: 4 residues within 4Å: Chain A: Y.197, Y.200 Ligands: 37X.3, 37X.4 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.200, A:Y.200, A:Y.200 37X.3: 3 residues within 4Å: Chain A: L.190 Ligands: 37X.2, 37X.4 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.190 37X.4: 8 residues within 4Å: Chain A: V.183, Y.200, W.202, W.203, Y.206, L.210 Ligands: 37X.2, 37X.3 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:V.183, A:W.203, A:Y.206, A:L.210 37X.7: 3 residues within 4Å: Chain B: P.23, E.26, R.106 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:R.106 Water bridges: B:P.23, B:Y.104, B:R.106, B:R.106, B:R.106

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.5: 2 residues within 4Å: Chain A: F.256, R.259 Ligand excluded by PLIP CL.8: 2 residues within 4Å: Chain B: F.256, R.259 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nie, L. et al., Crystal structure of human ELOVL fatty acid elongase 7 (ELOVL7). TO BE PUBLISHED

Release Date

2020-05-13

Peptides

Elongation of very long chain fatty acids protein 7: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Elongation of very long chain fatty acids protein 7